Viewing StudyNCT02400255



Ignite Creation Date: 2024-05-06 @ 3:53 AM
Last Modification Date: 2024-10-26 @ 11:40 AM
Study NCT ID: NCT02400255
Status: COMPLETED
Last Update Posted: 2023-12-18
First Post: 2015-03-18

Brief Title: Crenolanib Maintenance Following Allogeneic Stem Cell Transplantation in FLT3-positive Acute Myeloid Leukemia Patients
Sponsor: Arog Pharmaceuticals Inc
Organization: Arog Pharmaceuticals Inc

Organization Data

Organization: Arog Pharmaceuticals Inc
Class: INDUSTRY
Study ID: ARO-009
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Arog Pharmaceuticals Inc
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators